156 results
Page 3 of 8
8-K
spomdgtu 0f
21 Jun 22
Regulation FD Disclosure
10:30am
8-K
j6b mpmfcgx
13 Apr 22
Regulation FD Disclosure
8:00am
8-K
g2hrs
23 Feb 22
Regulation FD Disclosure
12:02pm
8-K
d06 z5lp0w0mh
8 Feb 22
MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:20am
8-K
ply zm0q4
5 Jan 22
MyMD Pharmaceuticals Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method of Treating Sarcopenia
9:28am
DEFA14A
cqzz191nj6v1
13 Dec 21
Additional proxy soliciting materials
5:15pm
DEFA14A
b3kh pxashz99r
3 Dec 21
Additional proxy soliciting materials
4:32pm
8-K
eexltyp1mw3a7
3 Dec 21
Regulation FD Disclosure
4:30pm
8-K
lc2m02w
16 Nov 21
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:25am
8-K
xdjv7j1jxilsljv8i7y
26 Oct 21
Regulation FD Disclosure
11:00am
8-K
8sr7o
19 Oct 21
Regulation FD Disclosure
10:30am
8-K
osco2n2qzpo413f
5 Oct 21
MyMD Pharmaceuticals to Detail its Two Upcoming Phase 2 Trials
10:00am
8-K
1zz1vk 7jbxgk
22 Sep 21
MyMD Pharmaceuticals Announces New Data Demonstrating 8,000
12:52pm
8-K
7u7v qfzc8i3kb
13 Sep 21
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan
5:30pm